These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21102649)

  • 21. Influenza vaccine--safe, effective, and mistrusted.
    Harris KM; Maurer J; Kellermann AL
    N Engl J Med; 2010 Dec; 363(23):2183-5. PubMed ID: 21105831
    [No Abstract]   [Full Text] [Related]  

  • 22. Influenza A (H1N1) 2009 pandemic virus: learning from the first wave, preparing for the second.
    Lee CK
    Med J Malaysia; 2010 Mar; 65(1):1-2. PubMed ID: 21265237
    [No Abstract]   [Full Text] [Related]  

  • 23. Preparing for H1N1 influenza: New Jersey preparedness efforts ongoing for nearly a decade.
    Howard H
    MD Advis; 2009; 2(4):23-6. PubMed ID: 21250538
    [No Abstract]   [Full Text] [Related]  

  • 24. [The influenza, a growing pandemic that calls for all possible provisions].
    Saliou P
    Bull Soc Pathol Exot; 2011 May; 104(2):95-6. PubMed ID: 21461900
    [No Abstract]   [Full Text] [Related]  

  • 25. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza H1N1 2009 in Canterbury: a case study in pandemic response co-ordination.
    Williams D; Begg A; Burgess K; Hider M; Jennings L; Martin-Smith M; McCormack P; Mitchell J; Pithie A; Schroeder P; Werno A
    J Prim Health Care; 2010 Dec; 2(4):323-9. PubMed ID: 21125074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy.
    Ajelli M; Merler S; Pugliese A; Rizzo C
    Epidemiol Infect; 2011 Jan; 139(1):68-79. PubMed ID: 20546633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pandemic 2009 influenza H1N1 virus vaccination: compliance and safety in a single hemodialysis center.
    Stavroulopoulos A; Stamogiannos G; Aresti V
    Ren Fail; 2010; 32(9):1044-8. PubMed ID: 20863207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine.
    Chao DY; Cheng KF; Hsieh YH; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH;
    Vaccine; 2011 Jan; 29(4):617-23. PubMed ID: 21095255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How did the 2008-2009 seasonal influenza vaccine affect the pandemic?
    Glezen WP
    Clin Infect Dis; 2010 Dec; 51(12):1380-2. PubMed ID: 21067354
    [No Abstract]   [Full Text] [Related]  

  • 31. H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.
    Kumar S; Fan J; Melzer-Lange M; Trost J; Havens PL; Willoughby RE; Chusid MJ; Henrickson KJ
    Pediatr Emerg Care; 2011 Sep; 27(9):804-7. PubMed ID: 21878831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Report of the international forum on pandemic influenza 2010 Qingdao, China, 24-25 July 2010.
    Varella A
    Vaccine; 2010 Nov; 28(48):7579-82. PubMed ID: 20887833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons learned from the H1N1 pandemic: the need to improve systematic vaccination in Sickle Cell Disease children. A multi center survey in Italy.
    Colombatti R; Perrotta S; Masera N; Palazzi G; Notarangelo LD; Pusiol A; Bonetto E; De Zen L; Nocerino A; Samperi P; Russo-Mancuso G; Sainati L
    Vaccine; 2011 Feb; 29(6):1126-8. PubMed ID: 21147126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of Ontario's pandemic vaccine program.
    Rolland-Harris E; Tepper M
    Vaccine; 2011 May; 29(22):3829; author reply 3830-1. PubMed ID: 20831912
    [No Abstract]   [Full Text] [Related]  

  • 35. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.
    Esposito S; Pugni L; Daleno C; Ronchi A; Valzano A; Serra D; Mosca F; Principi N
    Pediatrics; 2011 May; 127(5):e1161-8. PubMed ID: 21464195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.
    Loebermann M; Anders G; Brestrich G; Fritzsche C; Klammt S; Boršo D; Frimmel S; Riebold D; Reisinger EC
    Vaccine; 2011 Feb; 29(6):1228-34. PubMed ID: 21167116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons learnt from the H1N1 2009 pandemic - the Pune experience.
    Kulkarni R; Kinikar A
    Indian Pediatr; 2010 Sep; 47(9):810. PubMed ID: 21048274
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
    Meyer S; Adam M; Schweiger B; Ilchmann C; Eulenburg C; Sattinger E; Runte H; Schlüter M; Deuse T; Reichenspurner H; Costard-Jäckle A
    Transplantation; 2011 May; 91(9):1031-5. PubMed ID: 21358365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiological aspects of the influenza "pandemia" during 2009-2010 years].
    Belov AB; Ogarkov PI
    Voen Med Zh; 2010 Nov; 331(11):37-41. PubMed ID: 21395158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic variability of isolates of pandemic influenza A virus H1N1 isolated in Russia in 2009].
    Shikov AN; Sementsova AO; Demina OK; Sergeev AA; Berillo SA; Sergeeva EI; Vinokurova AV; Ishenina AV; Ternovoĭ VA; Agafonov AP; Drozdov IG
    Mol Gen Mikrobiol Virusol; 2011; (4):23-9. PubMed ID: 22312897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.